Filing Details
- Accession Number:
- 0001209191-10-017386
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-16 13:00:00
- Reporting Period:
- 2010-03-15
- Filing Date:
- 2010-03-16
- Accepted Time:
- 2010-03-16 19:37:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1333482 | J Kimberly Popovits | 301 Penobscot Drive Redwood City CA 94403 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-03-15 | 5,000 | $19.40 | 303,116 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-16 | 15,000 | $19.47 | 288,116 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 9, 2009.
- Represents weighted average sale price. Actual sale prices ranged from $19.27 to $19.65.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 12, 2009.
- Represents weighted average sale price. Actual sale prices ranged from $19.43 to $19.62.
Billionaire Hedge Funds
